SkinPen® Precision celebrates its fifth anniversary as Crown Aesthetics looks to expand its portfolio with BIOJUVE™ Launch
EverySkin is a reputable aesthetic clinic in London, UK, specialising in non-invasive and minimally invasive treatments for various skin concerns. The clinic was founded by Alice Sagnier and Bridget Healy in 2021.
The clinics have gained a reputation for personalised and effective treatments and offer a range of treatments, including injectables, laser treatments, chemical peels, and SkinPen® Precision, a medical-grade skin-remodelling micro-needling treatment.
In the summer of 2021, the clinic purchased their first SkinPen® Precision device, based on an assessment of devices available, EverySkin chose to opt for the FDA-Cleared, medical-grade device that had clinical evidence. The clinic prioritised a results-driven device that emphasised safety and efficacy for their patients.
Today, EverySkin has six SkinPen® devices, one in each of their six clinics and they have revolutionised how skin-remodelling and medical micro-needling is perceived among their patients throughout London. SkinPen microneedling has become one of EverySkin’s most popular treatments, treating approximately 200 patients a month across their six clinics. This has been projected to grow to treated 300+ patients per month in 2023, as part of the clinic’s growth strategy and plans.
EverySkin Clinic has capitalised on its return on investment from its first SkinPen purchase. They invested in training programs to ensure that all staff members provided clients with the same level of service and care. They leveraged the power of referrals, offering incentives to clients who referred their friends and family to the clinic. The clinic’s marketing strategy focused on targeting patients interested in skincare and beauty, and they invested in their advertising to attract new patients.
The most impactful strategy contributing to their growth was offering complimentary bespoke one-to-one consultations with patients. They find out more about the patient’s skin concerns, their skin journey, and their desired results, building trust and rapport with the patients. Maintaining these relationships has led to many referrals from the patient’s friends and family. Much emphasis has also gone into patient communication about the SkinPen Microneedling treatment, highlighting the natural benefits of the treatment for patients looking for longer-lasting results without surgery.
EverySkin has followed a carefully planned expansion strategy focussed on locations with high demand for aesthetic services making advanced treatments accessible to wider audiences. They also made sure to choose locations that were easily accessible and convenient for their clients. They aim to be part of the UK high street renaissance, providing more aesthetic treatments on the high street.
Alice Sagnier, Co-founder said,
We are pleased to express our satisfaction with our excellent partnership with Crown Aesthetics. Their diligent efforts in comprehending our distinctive business needs have been invaluable, and we have received remarkable support in our pursuit with their award-winning SkinPen Precision microneedling device.
Crown Aesthetics have delivered support to facilitate the rapid growth of our microneedling offering. We have integrated the SkinPen device into our six EverySkin clinics in London, with plans to expand our presence in the near future.
In conclusion, EverySkin’s expansion strategy focused on providing consistently high-quality services across all clinics while carefully choosing locations that meet clients’ convenience. By investing in leading medical devices – such as the SkinPen Precision device, to support their patient’s treatment demands – marketing, advertising, training, they attracted new clients and retained existing ones. Their clinic went from a single clinic to six clinics, becoming a successful regional aesthetics clinic chain provider.
What is SkinPen Precision Microneedling?
SkinPen Precision is the world’s first FDA-Cleared medical microneedling system that triggers the natural wound-healing process of the skin to treat acne scars and help improve the appearance of fine lines and wrinkles, surgical scars, stretch marks and enlarged pores.
SkinPen Precision utilises collagen induction therapy to deliver treatments through controlled micro-injuries to the skin, creating up to three million micro channels in a 30-minute treatment, eliciting the body’s natural wound-healing cascade. SkinPen Precision is also helpful in improving the cosmetic appearance of pigmentation conditions (dyschromia) by returning the skin to normal pigmentation activity.
Other Recent News
Crown Aesthetics Expands Further into the Asia Pacific Region
Crown Aesthetics Expands Further into the Asia Pacific Region Hires Jeff Sinclair, Executive Director, Sales, Asia Pacific Region
Award Winning Skin Science
Crown Aesthetics is a supreme medical aesthetics company that is committed to helping aesthetics clinics achieve more. By providing its superior products to aesthetic practices around the world, Crown Aesthetics ensures that clinics and clients get the best treatments available on the market.
SkinPen Precision sets the Gold Standard in Medical Skin Remodelling
At Crown Aesthetics, we have found that medical microneedling is growing in popularity each year within the aesthetic speciality, with more plastic surgeons, aesthetic practitioners and dermatologists turning their attention to skin remodelling to support their patients.
Crown Aesthetics’ UKI Sales Team to be led by Director of Sales, UKI, Simon Ofei
December 16, 2022 (Dallas, TX). Crown Aesthetics (“Crown”), a division of Crown Laboratories, Inc., is excited to announce Simon Ofei will join the organization as Director of Sales, United Kingdom & Ireland from 2023, January 3rd to support Crown’s UKI commercial efforts and further develop the SkinPen® Precision business, along with 2023 new product launches.